Literature DB >> 33812986

The hallmarks of ovarian cancer stem cells and niches: Exploring their harmonious interplay in therapy resistance.

Takeshi Motohara1, Go J Yoshida2, Hidetaka Katabuchi3.   

Abstract

The concept of a "cancer stem cell" has evolved over the past decades, and research on cancer stem cell biology has entered into a stage of remarkable progress. Cancer stem cells are a major determining factor contributing to the establishment of phenotypic and functional intratumoral heterogeneity in synchronization with their surrounding "cancer stem cell niches." They serve as the driving force for cancer initiation, metastasis, and therapeutic resistance in various types of malignancies. In verity, reciprocal interplay between ovarian cancer stem cells and their niches involves a complex but ingeniously orchestrated tumor microenvironment within the intraperitoneal milieu and especially contribute to chemotherapy resistance in patients with advanced ovarian cancer. Herein, we review the principles of our current understanding of the biological features of ovarian cancer stem cells, focusing mainly on the precise mechanisms underlying acquired chemotherapy resistance. Furthermore, we highlight the specific roles of various cancer-associated stromal and immune cells in creating possible cancer stem cell niches that regulate ovarian cancer stemness.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer stem cell; Cancer stem cell niche; Chemotherapy resistance; Ovarian cancer; Tumor microenvironment

Mesh:

Year:  2021        PMID: 33812986     DOI: 10.1016/j.semcancer.2021.03.038

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  8 in total

1.  Assessment of Tumor Heterogeneity in High-Grade Serous Ovarian Cancer: Mass Cytometry to Understand the Complex Tumor Biology.

Authors:  Luca Pasquini; Roberta Riccioni; Eleonora Petrucci
Journal:  Methods Mol Biol       Date:  2022

2.  The Value of the Stemness Index in Ovarian Cancer Prognosis.

Authors:  Hongjun Yuan; Qian Yu; Jianyu Pang; Yongzhi Chen; Miaomiao Sheng; Wenru Tang
Journal:  Genes (Basel)       Date:  2022-05-31       Impact factor: 4.141

3.  Stem Cell Factor SOX9 Interacts with a Cell Death Regulator RIPK1 and Results in Escape of Cancer Stem Cell Death.

Authors:  Mijung Oh; Chaeyeon Son; Seung Bae Rho; Minjeong Kim; Kyoungsook Park; Sang Yong Song
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

Review 4.  Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer.

Authors:  Bayley G Matthews; Nikola A Bowden; Michelle W Wong-Brown
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

Review 5.  Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities.

Authors:  Hadar Peeri; Hinanit Koltai
Journal:  Biomolecules       Date:  2022-03-24

Review 6.  Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular Mechanisms and Potential in the Fight against Ovarian Cancer and Stem Cells.

Authors:  Hinanit Koltai; Nurit Shalev
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

7.  Green Synthesis of Gold Nanoparticles and Study of Their Inhibitory Effect on Bulk Cancer Cells and Cancer Stem Cells in Breast Carcinoma.

Authors:  Jihui Wang; Na Liu; Qing Su; Yulong Lv; Chang Yang; Honglei Zhan
Journal:  Nanomaterials (Basel)       Date:  2022-09-24       Impact factor: 5.719

8.  BMI-1 Expression Heterogeneity in Endometriosis-Related and Non-Endometriotic Ovarian Carcinoma.

Authors:  Ludmila Lozneanu; Raluca Anca Balan; Ioana Păvăleanu; Simona Eliza Giuşcă; Irina-Draga Căruntu; Cornelia Amalinei
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.